These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 804567)

  • 1. In vivo cortisone sensitivity of nonspecific antitumor activity of Corynebacterium parvum-activated mouse peritoneal macrophages.
    Scott MT
    J Natl Cancer Inst; 1975 Mar; 54(3):789-92. PubMed ID: 804567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 3. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 5. Requirement for macrophages in lipopolysaccharide-stimulated mixed thymocyte cultures.
    Ritter J; Lohmann-Matthes ML; Sonntag HG; Fischer H
    Cell Immunol; 1975 Mar; 16(1):153-61. PubMed ID: 123174
    [No Abstract]   [Full Text] [Related]  

  • 6. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum.
    Basić I; Milas L; Grdina DJ; Withers HR
    J Natl Cancer Inst; 1975 Sep; 55(3):589-96. PubMed ID: 1159835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of Corynebacterium parvum and Corynebacterium liquefaciens on antitumor activity against sarcoma-180.
    Ideda H; Yamagata S; Toge T; Hattori T
    Gan; 1977 Apr; 68(2):233-5. PubMed ID: 892298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Corynebacterium parvum on Escherichia coli infection in mice.
    Yoshikai Y; Miake S; Mituyama M; Nomoto K
    J Gen Microbiol; 1982 Dec; 128(12):2857-63. PubMed ID: 6763935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytochemical and cytophysiological study of in vivo activated mouse peritoneal macrophages.
    Todoruţiu C; Mulea R; Daicoviciu D; Rişcă R
    Morphol Embryol (Bucur); 1981; 27(3):265-9. PubMed ID: 6460939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corynebacterium parvum-induced peritoneal exudate cells with rapid cytolytic activity against tumour cells are non-phagocytic cells with characteristics of natural killer cells.
    Ojo E; Haller O; Wigzell H
    Scand J Immunol; 1978; 8(3):215-22. PubMed ID: 705263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide.
    Tenu JP; Lederer E; Petit JF
    Eur J Immunol; 1980 Aug; 10(8):647-53. PubMed ID: 6772453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of peritoneal macrophages in cellular responses to mastocytoma in resistant and susceptible mice.
    Farber P; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():521-30. PubMed ID: 121034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
    Tuttle RL; Knick VC; Stopford CR; Wolberg G
    Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of Corynebacterium parvum on the activity of glycosidases and proteases of peritoneal macrophages in the mice].
    Scharfman A; Houdret N; Roussel P; Biserte G
    C R Acad Hebd Seances Acad Sci D; 1978 Sep; 287(4):317-20. PubMed ID: 102445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophages.
    Berd D; Mastrangelo MJ
    Br J Cancer; 1981 Dec; 44(6):819-27. PubMed ID: 7326193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.
    Lichtenstein AK; Kahle J; Berek J; Zighelboim J
    J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.